Hariklia Gakiopoulou Selected Research

Hariklia Gakiopoulou Research Topics

Disease

8	Neoplasms (Cancer) 05/2020 - 11/2003
6	Carcinoma (Carcinomatosis) 07/2014 - 11/2003
3	Neoplasm Metastasis (Metastasis) 03/2014 - 11/2003
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2021 - 01/2019
2	Inflammation (Inflammations) 11/2021 - 01/2013
2	Membranous Glomerulonephritis (Membranous Nephropathy) 05/2019 - 02/2011
2	Hypoxia (Hypoxemia) 01/2019 - 03/2014
2	Nephrotic Syndrome (Syndrome, Nephrotic) 09/2018 - 02/2011
2	Immunoglobulin Light-chain Amyloidosis 07/2017 - 01/2017
2	Thyroid Neoplasms (Thyroid Cancer) 04/2007 - 05/2006
1	Melanoma (Melanoma, Malignant) 03/2022
1	Hematologic Neoplasms (Hematological Malignancy) 03/2022
1	Kidney Diseases (Kidney Disease) 02/2022
1	Autoimmune Diseases (Autoimmune Disease) 11/2021
1	Stomach Neoplasms (Stomach Cancer) 05/2020
1	Hemoglobinuria 01/2020
1	Sclerosis 10/2019
1	Atrophy 10/2019
1	IGA Glomerulonephritis (IGA Nephropathy) 10/2019
1	Immunoglobulin G4-Related Disease 05/2019
1	Autoimmune Pancreatitis 05/2019
1	Diabetes Mellitus 05/2019
1	Interstitial Nephritis (Tubulointerstitial Nephritis) 05/2019
1	Pancreatitis 05/2019
1	Thromboinflammation 01/2019
1	Nephritis 01/2019
1	Fibrosis (Cirrhosis) 01/2019
1	Nephrosclerosis 01/2018
1	Hypertension (High Blood Pressure) 01/2018
1	Renal Cell Carcinoma (Grawitz Tumor) 03/2014
1	Carcinogenesis 07/2012
1	Adenocarcinoma 07/2012
1	Astrocytoma (Pilocytic Astrocytoma) 10/2011
1	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 02/2011
1	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 02/2011
1	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 06/2010
1	Acute Kidney Injury (Acute Renal Failure) 06/2010
1	Glomerulonephritis 06/2010
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 06/2010
1	Castleman Disease (Castleman's Disease) 06/2010
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 06/2010
1	Thyroid Diseases (Thyroid Disease) 01/2010
1	Colonic Neoplasms (Colon Cancer) 02/2007
1	Lymphatic Metastasis 02/2007

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 01/2019 - 03/2002
5	Replication Protein AIBA 05/2020 - 02/2007
2	Biomarkers (Surrogate Marker)IBA 02/2022 - 10/2011
2	Bortezomib (Velcade)FDA Link 07/2017 - 01/2017
2	Indicators and Reagents (Reagents)IBA 10/2011 - 02/2007
2	ParaffinIBA 07/2005 - 03/2002
1	Histone Deacetylase InhibitorsIBA 03/2022
1	Histones (Histone)IBA 03/2022
1	Histone Deacetylases (Histone Deacetylase)IBA 03/2022
1	AlarminsIBA 11/2021
1	Interleukin-33IBA 11/2021
1	IronIBA 01/2020
1	HemosiderinIBA 01/2020
1	Complement System Proteins (Complement)IBA 10/2019
1	Immunoglobulin A (IgA)IBA 10/2019
1	SteroidsIBA 05/2019
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2019
1	TinIBA 05/2019
1	Immunoglobulin G (IgG)IBA 05/2019
1	Immunoglobulins (Immunoglobulin)IBA 05/2019
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2019
1	Bosentan (Tracleer)FDA Link 01/2019
1	Endothelin-1 (Endothelin 1)IBA 01/2019
1	Thromboplastin (Tissue Factor)IBA 01/2019
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2019
1	Interleukin-17 (Interleukin 17)IBA 01/2019
1	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2018
1	ChloridesIBA 01/2018
1	Lenalidomide (CC 5013)FDA Link 07/2017
1	Immunoglobulin FragmentsIBA 01/2017
1	CXC ChemokinesIBA 07/2014
1	CXCR4 Receptors (CXCR4 Receptor)IBA 07/2014
1	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 07/2014
1	Chemokine ReceptorsIBA 03/2014
1	CXCR ReceptorsIBA 03/2014
1	Transcription Factors (Transcription Factor)IBA 03/2014
1	CytokinesIBA 03/2014
1	Interleukin-8 (Interleukin 8)IBA 03/2014
1	Biological ProductsIBA 03/2014
1	Cell Adhesion MoleculesIBA 01/2013
1	Cadherins (E-Cadherin)IBA 01/2013
1	CateninsIBA 01/2013
1	CyclinsIBA 10/2011
1	podocalyxinIBA 02/2011
1	Interleukin-6 (Interleukin 6)IBA 06/2010
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2010
1	AutoantibodiesIBA 06/2010
1	Carcinoembryonic AntigenIBA 01/2010
1	Colloids (Colloid)IBA 04/2007
1	Cytotoxins (Cytolysins)IBA 02/2007
1	RNA (Ribonucleic Acid)IBA 05/2006
1	Fibrillin-1IBA 05/2006
1	FibrillinsIBA 05/2006
1	Messenger RNA (mRNA)IBA 05/2006

Therapy/Procedure

5	Therapeutics 03/2022 - 07/2017
2	Aftercare (After-Treatment) 05/2019 - 01/2017